Chapman Investment Management, LLC Pfizer Inc Transaction History

Chapman Investment Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 25, 2023	SELL	$39.39 - $51.28 $724,579 - $943,295	-18,395 Reduced 73.35%	6,682 $272,000
Q3 2022 Nov 01, 2022	SELL	$43.76 - $53.42 $1.6 Million - $1.95 Million	-36,550 Reduced 59.31%	25,077 $1.1 Million
Q2 2022 Aug 01, 2022	SELL	$46.53 - $55.17 $38,852 - $46,066	-835 Reduced 1.34%	61,627 $3.23 Million
Q1 2022 May 09, 2022	BUY	$45.75 - $56.69 $16,424 - $20,351	359 Added 0.58%	62,462 $3.23 Million
Q4 2021 Jan 20, 2022	BUY	$41.32 - $61.25 $43,468 - $64,435	1,052 Added 1.72%	62,103 $3.67 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $212,107 - $272,469	5,404 Added 9.71%	61,051 $2.63 Million
Q2 2021 Aug 03, 2021	BUY	$35.91 - $40.68 $2 Million - $2.26 Million	55,647 New	55,647 $2.18 Million

3,260

3.73B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Chapman Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Chapman Investment Management, LLC with notifications on news.